We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sandoz Lawsuit Vs. European Commission Highlights Uncertainties Over Biogenerics

Law360 (April 8, 2004, 12:00 AM EDT) -- In a case likely to have broad implications, Swiss generic drug maker Sandoz has filed a lawsuit against the European Commission for denying approval of the world’s first generic biotech drug.

In a decision that took the market by surprise, the European Union’s executive body rejected Sandoz’ application of its Omnitrop generic human growth hormone, citing filing irregularities.

However, Sandoz says it believes it used an appropriate pathway to file the drug, and officials told the media they were engaged in an ongoing dialogue with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.